17-alpha-hydroxyprogesterone has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Dissen, GA; Garcia-Rudaz, C; Mayer, C; Mayerhofer, A; Ojeda, SR; Paredes, A | 1 |
| Bennett, W; Cockrell, K; Fournier, L; Granger, JP; Keiser, SD; Lamarca, B; Martin, JN; Parrish, MR; Veillon, EW | 1 |
| Anakk, S; Finegold, MJ; McKenna, NJ; Moore, DD; Ochsner, SA; Watanabe, M | 1 |
| Brehme, U; Bruck, B; Finking, G; Gugel, N; Hanke, H; Hanke, S; Schmahl, FW; Wehrmann, M | 1 |
6 other study(ies) available for 17-alpha-hydroxyprogesterone and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Apoptosis; Cells, Cultured; Disease Models, Animal; Estradiol; Female; Follicular Fluid; Gonadotropins, Equine; Granulosa Cells; Humans; Mice; Mice, Transgenic; Nerve Growth Factor; Ovarian Cysts; Ovary; Polycystic Ovary Syndrome; Puberty; Reproduction; RNA, Messenger; Testosterone | 2009 |
Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Antihypertensive Agents; Blood Pressure Determination; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Endothelin-1; Female; Humans; Hypertension, Pregnancy-Induced; Pregnancy; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2009 |
Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Bile Acids and Salts; Biliary Tract; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Disease Models, Animal; Enzyme Induction; Humans; Liver; Male; Mice; Mice, Congenic; Mice, Inbred C57BL; Mice, Knockout; Receptors, Cytoplasmic and Nuclear; Steroid 12-alpha-Hydroxylase; Steroid 17-alpha-Hydroxylase | 2011 |
Aortic plaque size and endometrial response in cholesterol-fed rabbits treated with estrogen plus continuous or sequential progestin.
Topics: 17-alpha-Hydroxyprogesterone; Animal Feed; Animals; Aorta; Aorta, Thoracic; Area Under Curve; Arteriosclerosis; Body Weight; Cholesterol; Disease Models, Animal; Drug Therapy, Combination; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Progestins; Rabbits; Triglycerides; Tunica Intima | 1999 |